Ventilator associated infection (VAI) develops in patients receiving mechanical ventilation for more than 48 hours, becoming a critical risk factor for mortality in intensive care units. This is not just a statistical unit, but a specific complication that requires an immediate review of treatment tactics and antibiotic therapy. Doctors diagnose VAI when, during mechanical ventilation, new infiltrates appear on a chest x-ray in combination with fever, purulent sputum and changes in the leukocyte count.

The mechanism of occurrence of the pathology is often associated with a violation of the protective barriers of the respiratory tract, when the endotracheal tube serves as a conductor for pathogenic bacteria from the oropharynx to the lower parts of the lungs. The microflora changes rapidly, and opportunistic organisms that previously did not pose a threat begin to actively multiply, causing a severe inflammatory process. Understanding what's behind the acronym VAI, allows medical staff and relatives of patients to consciously approach the issues of prevention and control of infections in the hospital.

Clinical picture and diagnostic criteria

Diagnosis of this condition is based on a complex of clinical, laboratory and instrumental data that must be collected over time. The main sign is the appearance of new or progressive infiltrates on a radiograph that cannot be explained by other causes, such as pulmonary edema or atelectasis. However, the X-ray picture is nonspecific, so changes in the systemic inflammatory response of the body play a key role.

Fever of unknown origin, an increase in body temperature above 38°C or, conversely, hypothermia below 36°C, are often the first alarm signals for the resuscitator. In parallel with the temperature reaction, a change in the nature of secretions from the respiratory tract is observed: sputum becomes purulent, changes color and smell, which indicates bacterial aggression. A blood test reveals leukocytosis with a shift in the leukocyte formula to the left, indicating an acute infectious process.

To confirm the diagnosis and select effective therapy, a microbiological study is necessary. Bronchoalveolar lavage or aspiration of tracheal contents make it possible to identify the pathogen and determine its sensitivity to antibacterial drugs. Without an accurate identification of the pathogen, treatment may be ineffective, leading to chronicity of the process or the development of sepsis.

  • 🦠 The appearance of new infiltrates on a chest x-ray that are not associated with heart failure.
  • 🌡️ Persistent increase in body temperature or hypothermia, accompanied by chills and sweating.
  • 💨 Change in the nature of phlegm: the appearance of pus, unpleasant odor or blood impurities.
  • 🩸 Leukocytosis or leukopenia in a general blood test, indicating a systemic inflammatory reaction.

⚠️ Attention: Self-medication in intensive care conditions is impossible. Any changes in the patient’s condition on mechanical ventilation require immediate medical intervention and correction of the treatment protocol.

📊 How do you assess the level of awareness about the risks of mechanical ventilation?
Low
Medium
High
I find it difficult to answer

Main pathogens and routes of transmission

The etiological structure of VAI is diverse and depends on the length of the patient's hospital stay, previous antibiotic therapy and local epidemiological conditions. The most common pathogens are gram-negative bacteria, such as Pseudomonas aeruginosa and Acinetobacter baumannii, which are highly resistant to disinfectants and antibiotics. These microorganisms are able to form biofilms on the surface of endotracheal tubes, protecting themselves from the action of the immune system and drugs.

Gram-positive flora, in particular Staphylococcus aureus (Staphylococcus aureus), also occupies a significant place in the structure of morbidity, especially in the first days of ventilation. Strains resistant to methicillin are especially dangerous, as they require the use of backup and toxic drugs. Viral and fungal infections are less common, but their likelihood increases in patients with severe immunodeficiency.

The routes of infection transmission are predominantly endogenous, when bacteria from the patient’s own microflora enter the sterile parts of the lungs. However, we cannot exclude an exogenous route associated with violation of aseptic rules when sanitizing the respiratory tract or using contaminated equipment. Intensive care personnel, equipment, inhalation solutions - all this can become a source of cross-infection if strict hygiene standards are not observed.

Risk factors for complications

There are a number of factors that significantly increase the likelihood of developing infection in mechanically ventilated patients. The duration of the procedure itself is one of the main criteria: the risk increases with every day that the tube is in the trachea. Violation of the cough reflex and mucociliary clearance leads to stagnation of secretions, which becomes an ideal breeding ground for the proliferation of bacteria.

Comorbidities such as diabetes, chronic obstructive pulmonary disease (COPD) or kidney failure reduce the body's reserve capacity. Immunosuppressioncaused by the use of cytostatics, corticosteroids or the critical condition itself, makes the patient defenseless against attack by pathogens. Also an important factor is the frequency and quality of the sanitation of the tracheobronchial tree.

Technical aspects of mechanical ventilation, such as high airway pressure or large dead spaces in the ventilator circuit, can contribute to mucosal damage and infection. The position of the patient in bed also plays a role: a horizontal position increases the risk of gastric contents reflux into the airways.

Risk factor Mechanism of influence Degree of influence
Duration of mechanical ventilation > 48 hours Damage to the mucosa, formation of biofilms High
Previous antibiotic therapy Selection of resistant strains of bacteria High
Concomitant diseases Decreased immune response of the body Average
Violation of asepsis rules Exogenous contamination of the respiratory tract Critical

Prevention Strategies and Safety Protocols

Prevention of ventilator-associated infection is a priority in the work of intensive care units. The package of measures known as the “VAI prevention package” includes strict adherence to hygiene standards, rational use of antibiotics and nursing techniques. Daily assessment of the possibility of extubation helps to minimize the time the patient remains on the ventilator.

Oral hygiene plays a key role in preventing bacterial migration. Regular treatment with antiseptic solutions such as chlorhexidine reduces the bacterial load in the oropharynx. The use of endotracheal tubes with supra-cuff aspiration allows secretions that accumulate above the inflatable cuff to be removed, preventing it from flowing into the lower parts of the lungs.

Monitoring the pressure in the endotracheal tube cuff is also a mandatory element of prevention. Optimal pressure (20-30 cm of water column) ensures tightness, but does not cause ischemia of the tracheal mucosa. Disturbance of this balance can lead to both aspiration and necrosis of tracheal tissue.

  • 🧼 Regular oral hygiene with chlorhexidine 0.12-0.2% every 4-6 hours.
  • 🛌 Giving the patient a semi-sitting position (30-45 degrees) in the absence of contraindications.
  • 💊 Conduct daily assessment of the need for continued ventilation and sedation.
  • 🧤 Strict adherence to hand hygiene rules by medical personnel before any contact.

⚠️ Attention: The use of open suction systems requires special care, as they increase the risk of respiratory tract contamination compared to closed systems.

Modern methods of treatment and antibiotic therapy

Treatment of established infection requires a comprehensive approach, including antimicrobial therapy, respiratory support and treatment of the underlying disease. The choice of antibiotic is carried out empirically, based on local data on the resistance of microorganisms, with subsequent correction after receiving culture results. Combinations of drugs from different groups are often used to expand the spectrum of action.

Respiratory support is aimed at ensuring adequate oxygenation and ventilation of the lungs with minimal barotraumatic effects. Ventilation modes are selected individually, taking into account the mechanical properties of the patient’s lungs. An important aspect is regular sanitation of the respiratory tract to remove viscous secretions and prevent bronchial obstruction.

Adjuvant therapy includes immunomodulators, antioxidants and agents that improve the rheological properties of sputum. In severe cases, with the development of multiple organ failure, the use of extracorporeal hemocorrection methods is required. The duration of the course of antibiotic therapy is determined by the dynamics of clinical indicators and can range from 7 to 21 days.

Forecast and possible consequences

The prognosis for ventilator-associated infection depends on the timeliness of diagnosis, the virulence of the pathogen and the initial condition of the patient. With early detection and proper treatment, complete recovery of lung function is possible. However, in some cases, infection can lead to chronicity of the process, the formation of fibrosis of the lung tissue and a persistent decrease in respiratory reserve.

Complications can be local, such as lung abscess, pneumothorax, or pleural empyema, and systemic, including sepsis and multiple organ failure. Mortality in severe forms of VAI caused by multidrug-resistant flora remains high, especially in elderly patients and those with concomitant pathology. Prolonged stay in intensive care increases the risk of developing other hospital-acquired infections.

Rehabilitation after an infection takes time and includes breathing exercises, physiotherapy and general strengthening measures. It is important to continue monitoring the condition of the lungs even after extubation, as relapses or the development of late complications are possible. The quality of life of patients who have suffered severe VAI may be temporarily reduced, but with the right approach, most return to a full life.

What does the term “multidrug resistance” mean in the context of VAI?

Multidrug resistance means resistance of microorganisms to three or more classes of antimicrobial drugs. This makes treatment extremely difficult, since standard antibiotic regimens are ineffective, and doctors are forced to use reserve drugs, which are often more toxic.

Is it possible to completely prevent the development of VAI?

It is impossible to completely eliminate the risk of developing VAI, since the very fact of a foreign body being in the respiratory tract disrupts natural protective mechanisms. However, strict adherence to prevention protocols can reduce the likelihood of infection to a minimum.

How long does it take to treat ventilatory pneumonia?

The duration of treatment varies from 7 to 21 days and depends on the type of pathogen, the severity of the patient's condition and the speed of clinical response to therapy. The decision to stop antibiotic therapy is made by the attending physician based on the dynamics of symptoms and laboratory parameters.

Is VAI contagious to others?

VAI itself is not contagious to healthy people under normal conditions. However, the bacteria that cause the infection can be passed from patient to patient through staff's hands or equipment if proper hygiene is not followed, which is especially dangerous for other frail patients.

⚠️ Attention: Interrupting the course of antibiotics ahead of time prescribed by the doctor can lead to a relapse of the infection and the formation of resistant strains of bacteria.